Undertreatment of Pancreatic Cancer: Role of Surgical Pathology
- 26 August 2020
- journal article
- research article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 28 (3) , 1581-1592
Abstract
Current guidelines recommend treatment of early-stage pancreatic cancer with surgical resection and chemotherapy. Undertreatment can occur after resectionKeywords
This publication has 26 references indexed in Scilit:
- Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and SurvivalJournal of Gastrointestinal Surgery, 2013
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic CancerJAMA, 2013
- Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomesHPB, 2012
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic CancerBritish Journal of Cancer, 2009
- The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United StatesAnnals of Surgical Oncology, 2008
- Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic CancerJournal of Gastrointestinal Surgery, 2007
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic CancerJAMA, 2007
- Pancreaticoduodenectomy for Cancer of the Head of the Pancreas 201 PatientsAnnals of Surgery, 1995
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992